Comparison of the Efficacy, Safety, Pharmacokinetic and Immunogenicity of UJVIRA (ZRC-3256, Trastuzumab Emtansine) With the Kadcyla (Trastuzumab Emtansine) in the Treatment of HER2-Positive Metastatic Breast Cancer: A Randomized, Open-Label, Multicenter Study in India.
| Autor: | Thungappa, Satheesh Chiradoni, Maksud, Tanveer, Raut, Nirmal, Nagarkar, Rajnish, Batra, Ullas, Kumar, Sanjeev, Parma, Deven, Study Investigator Group, Chiradoni Thungappa, Satheesh, Parmar, Deven |
|---|---|
| Zdroj: | Clinical Breast Cancer; Jun2022, Vol. 22 Issue 4, p300-307, 8p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|
Full Text from ScienceDirect